Substituted bicyclic compounds as bromodomain inhibitors
US9636328B2 · kind B2 · utility
20Cited by
8References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 20, 2014 |
| Grant date | May 2, 2017 |
| Priority date | — |
| Expiry date | Jun 20, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to substituted bicyclic compounds, which are useful for inhibition of BET protein function by binding to bromodomains, pharmaceutical compositions comprising these compounds, and use of the compounds and compositions in therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.